Clinical trials: Monotherapy After PCI

ST-segment Elevation Myocardial Infarction (STEMI)

Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy

• Not yet recruiting
• Age: All ages

This multicenter, randomized controlled trial in China aims to enroll 2,400 patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (PCI) within 24 hours post-fibrinolysis.

Trial name

BRIGHT-FIT (NCT06861374)

Testing

Bivalirudin, Unfractionated heparin

Volunteers

2,400 people

Sponsor

First Affiliated Hospital Xi'an Jiaotong University